A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B

Completed · Phase 3 · Has a placebo group

Conditions studied: Macular Telangiectasia Type 2

In brief

This study is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of the NT-501 implants in participants with macular telangiectasia type 2.

Key facts

Study ID

NCT03319849

Run by

Neurotech Pharmaceuticals

People needed

119

Starts

2018-01-22

Expected to finish

2022-09-23

Last updated by the study team

2024-09-24

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Retina Vitreous Assoc — Beverly Hills, California, United States
• Retina Consultants of Southern Colorado, P.C. — Colorado Springs, Colorado, United States
• Emory University Eye Center — Atlanta, Georgia, United States
• Northwestern Medical Group — Chicago, Illinois, United States
• Elman Retina Group, PA — Baltimore, Maryland, United States
• Massachusetts Eye and Ear Infirmary Ophthalmology Clinical Research Office — Boston, Massachusetts, United States
• New England Retina Consultants — Springfield, Massachusetts, United States
• University of Michigan, Kellogg Eye Center — Ann Arbor, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• The Retina Institute — Chesterfield, Missouri, United States
• Retina Center of New Jersey - Envision Ocular, LLC — Bloomfield, New Jersey, United States
• Flaum Eye - University of Rochester — Rochester, New York, United States
• University of Rochester Strong Memorial Hospital — Rochester, New York, United States
• Cincinnati Eye Institute — Cincinnati, Ohio, United States
• Tulsa Retina Consultants — Tulsa, Oklahoma, United States
• Retina Northwest, PC — Portland, Oregon, United States
• Scheie Eye Institute - University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Palmetto Retina Center — West Columbia, South Carolina, United States
• Southeastern Retina Associates, PC — Knoxville, Tennessee, United States
• Austin Clinical Research, LLC — Austin, Texas, United States
• Retina Consultants of Texas — Bellaire, Texas, United States
• Retina Center of Texas — Southlake, Texas, United States
• Save Sight Institute, Sydney — Sydney, New South Wales, Australia
• Centre for Eye Research Australia Macular Research Unit — East Melbourne, Victoria, Australia
• Klinik at Freiberg, Germany — Freiburg im Breisgau, Baden-Wurttemberg Germany, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.